Patents Examined by H. M. S. Snead
  • Method of lowering LDL cholesterol in blood
    Patent number: 4920115
    Abstract: Therapeutic amounts of DHEA are administered to human patients for the treatment and prevention of such disorders as atherosclerosis, angina, diabetes, obesity and congestive heart failure. Administering therapeutic quantities of DHEA to human patients has been found to reduce body fat mass and increase muscle mass, lower serum LDL cholesterol levels, lower serum apoB levels, and not affect tissue sensitivity to insulin.
    Type: Grant
    Filed: December 28, 1988
    Date of Patent: April 24, 1990
    Assignee: Virginia Commonwealth University
    Inventors: John E. Nestler, Cornelius O. Barlascini, John N. Clore, William G. Blackard